Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Gastroenterology

Journal Scan / Research · August 24, 2022

Aminotransferase Levels Predict Long-Term Survival in Patients With Autoimmune Hepatitis Type 1

Clinical Gastroenterology and Hepatology


Additional Info

Disclosure statements are available on the authors' profiles:

Clinical Gastroenterology and Hepatology
Aminotransferases During Treatment Predict Long-Term Survival in Patients With Autoimmune Hepatitis Type 1: A Landmark Analysis
Clin. Gastroenterol. Hepatol. 2022 Aug 01;20(8)1776-1783.e4, M Biewenga, X Verhelst, M Baven-Pronk, H Putter, A van den Berg, I Colle, J Schouten, F Sermon, C Van Steenkiste, H van Vlierberghe, A van der Meer, B van Hoek

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading